Autres langues Gilead Sciences, Inc.

Actions

GILD

US3755581036

Produits pharmaceutiques

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 29/07/2026			Après clôture 02:00:00
132,73 ^USD	-1,18 %		130,86	-1,41 %

07:01	Merck et Wellcome s'associent à un groupe de santé mondial pour produire un vaccin contre Ebola destiné aux essais cliniques	RE
28/07	Atea Pharmaceuticals : le traitement combiné atteint ses objectifs en phase 3 dans l'hépatite C	MT

Autres langues

07:01	Merck, Wellcome partner with global health group to make Ebola vaccine for clinical trials
29/07	South Africa's Next HIV Battle Isn't About Science, It's About Access
28/07	Atea Pharmaceuticals Says Combination Drug Meets Endpoints in Phase 3 Hepatitis C Trial
24/07	Unternehmenskalender vom 27. bis 31. Juli 2026
24/07	Merck otorga licencias de su píldora experimental contra el VIH a fabricantes de genéricos en 129 países
24/07	Gilead Sciences, Inc. Recommends Trodelvy Plus Keytruda In PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
24/07	Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer
24/07	Merck licenses experimental HIV pill to generic makers in 129 countries
24/07	CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
24/07	AIDS 2026 - Gilead, Governments Must Make HIV Prevention Medicine More Accessible
23/07	Positive Interim Findings On New Once-Weekly HIV Treatment Pill
22/07	What Bundibugyo Ebola vaccines and treatments are under development
21/07	Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
21/07	Gilead Sciences Shares Fall After Downgrade From Leerink Partners
21/07	Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
21/07	Analystenempfehlungen: VAT, Belimo, Richemont, Salesforce, Goldman Sachs, Crowdstrike…
21/07	Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
21/07	Analyst recommendations: Gilead, Salesforce, Goldman Sachs, Carvana, Crowdstrike…
16/07	Kalshi to allow bets on clinical trials, FDA decisions
15/07	African markets - factors to watch on July 15
14/07	Congo begins trial of Gilead's experimental antiviral for Ebola Bundibugyo
08/07	Biopharma Companies' Second-Half Performance to be Largely Driven by Fundamentals, Morgan Stanley Says
08/07	Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says
06/07	Analyst recommendations: Chubb, Delta Air Lines, Pfizer, AMD, Dow…
03/07	Trial for Ebola treatment starts in DR Congo